wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33411920-19690A37-569B-4D3E-9716-24208F0175BE
Q33411920-19690A37-569B-4D3E-9716-24208F0175BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411920-19690A37-569B-4D3E-9716-24208F0175BE
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
P2860
Q33411920-19690A37-569B-4D3E-9716-24208F0175BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411920-19690A37-569B-4D3E-9716-24208F0175BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b316ea0f0d7588f743cd8126dd20a0f6b010634
P2860
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.